Published in Inflamm Bowel Dis on March 01, 2014
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut (2015) 1.76
Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. MBio (2015) 1.00
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol (2015) 0.98
Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci (2014) 0.92
Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review. Inflamm Bowel Dis (2015) 0.87
Impact of stressor exposure on the interplay between commensal microbiota and host inflammation. Gut Microbes (2014) 0.87
Faecalibacterium prausnitzii inhibits interleukin-17 to ameliorate colorectal colitis in rats. PLoS One (2014) 0.86
Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol Nutr Food Res (2016) 0.85
A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe. Microb Cell Fact (2015) 0.85
Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice. Gut Microbes (2015) 0.83
Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Sci Rep (2016) 0.83
Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis. PLoS One (2015) 0.81
Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Sci Rep (2016) 0.79
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J (2017) 0.78
Dietary Enterococcus faecalis LAB31 improves growth performance, reduces diarrhea, and increases fecal Lactobacillus number of weaned piglets. PLoS One (2015) 0.78
Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation. Hum Vaccin Immunother (2014) 0.78
Microbiota and mucosal immunity in amphibians. Front Immunol (2015) 0.78
Mucosa-Associated Faecalibacterium prausnitzii Phylotype Richness Is Reduced in Patients with Inflammatory Bowel Disease. Appl Environ Microbiol (2015) 0.78
Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic. Front Microbiol (2017) 0.78
Indole - the scent of a healthy 'inner soil'. Microb Ecol Health Dis (2015) 0.77
Convergence of External Crohn's Disease Risk Factors on Intestinal Bacteria. Front Immunol (2015) 0.75
A Personalized Approach to Managing Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y) (2016) 0.75
Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii Shows a Protective Effect on DNBS and DSS-Induced Colitis Model in Mice through Inhibition of NF-κB Pathway. Front Microbiol (2017) 0.75
The Microbiota Determines Susceptibility to Experimental Autoimmune Uveoretinitis. J Immunol Res (2016) 0.75
Bugs, genes, fatty acids, and serotonin: Unraveling inflammatory bowel disease? F1000Res (2015) 0.75
Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice. Front Microbiol (2016) 0.75
Dual role of MAPK pathway in the regulation of intestinal barrier function. Inflamm Bowel Dis (2014) 0.75
Microbiota-Specific CD4CD8αα Tregs: Role in Intestinal Immune Homeostasis and Implications for IBD. Front Immunol (2015) 0.75
Outer Membrane Vesicles and Soluble Factors Released by Probiotic Escherichia coli Nissle 1917 and Commensal ECOR63 Enhance Barrier Function by Regulating Expression of Tight Junction Proteins in Intestinal Epithelial Cells. Front Microbiol (2016) 0.75
The dual role of MAPK pathway in the regulation of intestinal barrier: the role of the commensal bacterium Faecalibacterium prausnitzii on this regulation. Inflamm Bowel Dis (2014) 0.75
Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial Applications. Front Microbiol (2017) 0.75
Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol (2017) 0.75
Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature (2005) 31.60
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med (2002) 23.42
Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet (2007) 15.46
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Hypothalamic regulation of sleep and circadian rhythms. Nature (2005) 8.23
Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet (2009) 6.35
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66
Altered microRNA expression in human heart disease. Physiol Genomics (2007) 5.64
Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev (2009) 5.21
Sleep state switching. Neuron (2010) 4.94
Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science (2009) 4.45
From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal (2007) 3.49
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology (2011) 3.29
The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology (2003) 3.19
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A (2008) 3.13
Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci U S A (2008) 3.10
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci U S A (2007) 3.00
The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells. Cell (2008) 2.94
Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 2.84
The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol (2012) 2.83
Pathway level analysis of gene expression using singular value decomposition. BMC Bioinformatics (2005) 2.78
A broad role for melanopsin in nonvisual photoreception. J Neurosci (2003) 2.78
The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology (2011) 2.71
ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol (2008) 2.70
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
A preliminary report of penile transplantation. Eur Urol (2006) 2.54
MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci U S A (2010) 2.53
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev (2009) 2.41
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
Differential rescue of light- and food-entrainable circadian rhythms. Science (2008) 2.20
MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol (2009) 2.18
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut (2012) 2.17
Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J Neurosci (2003) 2.15
Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology (2013) 2.13
Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood (2009) 2.11
Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun (2010) 2.09
Inhibition of angiogenesis by the antifungal drug itraconazole. ACS Chem Biol (2007) 2.00
Roads to polyploidy: the megakaryocyte example. J Cell Physiol (2002) 2.00
The hypothalamic integrator for circadian rhythms. Trends Neurosci (2005) 1.99
Reassessment of the structural basis of the ascending arousal system. J Comp Neurol (2011) 1.93
RNA catalyses nuclear pre-mRNA splicing. Nature (2013) 1.86
Afferents to the ventrolateral preoptic nucleus. J Neurosci (2002) 1.86
A Munc13/RIM/Rab3 tripartite complex: from priming to plasticity? EMBO J (2005) 1.86
Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology (2010) 1.85
New fluorescent protein reporters for use with the Drosophila Gal4 expression system and for vital detection of balancer chromosomes. Genesis (2002) 1.80
Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus. Chem Biol (2011) 1.80
Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics. Sci Transl Med (2012) 1.80
The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology (2006) 1.75
Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Transl Med (2012) 1.73
A minimal domain responsible for Munc13 activity. Nat Struct Mol Biol (2005) 1.68
Two-dimensional nanocrystals produced by exfoliation of Ti3 AlC2. Adv Mater (2011) 1.66
Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem (2005) 1.64
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia. Cancer Cell (2012) 1.61
Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol (2006) 1.61
Prediction of surface exposed proteins in Streptococcus pyogenes, with a potential application to other Gram-positive bacteria. Proteomics (2009) 1.58
Munc13 C2B domain is an activity-dependent Ca2+ regulator of synaptic exocytosis. Nat Struct Mol Biol (2010) 1.58
The relationship between PTH and 25-hydroxy vitamin D early in pregnancy. Clin Endocrinol (Oxf) (2011) 1.56
Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci U S A (2008) 1.54
Factors affecting outcomes in Crohn's disease over 15 years. Gut (2012) 1.52
Long-term outcome of patients with Crohn's disease who respond to azathioprine. Clin Gastroenterol Hepatol (2012) 1.52
The protective role of silicon in the Arabidopsis-powdery mildew pathosystem. Proc Natl Acad Sci U S A (2006) 1.51
SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res (2012) 1.50
A hierarchical model for estimating response time distributions. Psychon Bull Rev (2005) 1.50
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun (2012) 1.49
The effect of repeated etomidate anesthesia on adrenocortical function during a course of electroconvulsive therapy. J ECT (2011) 1.49
Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res (2003) 1.48
Exogenous surfactant may improve oxygenation but not mortality in adult patients with acute lung injury/acute respiratory distress syndrome: a meta-analysis of 9 clinical trials. J Cardiothorac Vasc Anesth (2012) 1.47
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact (2011) 1.45
Protein secretion in Lactococcus lactis : an efficient way to increase the overall heterologous protein production. Microb Cell Fact (2005) 1.45
Inhibition of the human thioredoxin system. A molecular mechanism of mercury toxicity. J Biol Chem (2008) 1.45
Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension. Ann Thorac Surg (2007) 1.44
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat Commun (2013) 1.43
A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol (2005) 1.43
Sera from patients with Crohn's disease break bacterial lipopolysaccharide tolerance of human intestinal epithelial cells via MD-2 activity. Innate Immun (2010) 1.43
Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc Natl Acad Sci U S A (2010) 1.43
The pontine REM switch: past and present. J Physiol (2007) 1.42
An introduction to Bayesian hierarchical models with an application in the theory of signal detection. Psychon Bull Rev (2005) 1.42
Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J (2011) 1.42
Two-dimensional transition metal carbides. ACS Nano (2012) 1.42
Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One (2011) 1.41
Impact of lactobacilli on orally acquired listeriosis. Proc Natl Acad Sci U S A (2012) 1.38
Structure and function of the interacting domains of Spire and Fmn-family formins. Proc Natl Acad Sci U S A (2011) 1.36
Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am (2005) 1.35
Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2011) 1.33
Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest (2010) 1.33
Chemical enhancement of torsinA function in cell and animal models of torsion dystonia. Dis Model Mech (2010) 1.33